[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Incorporated (VRTX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript",
    "summary": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Goldman Sachs 46th Annual Global Healthcare Conference Call June 10, 2025 2:40 PM ETCompany...",
    "url": "https://finnhub.io/api/news?id=ef4d70f5a7a8d4ad5562c2271493d452c19b86c8e4211e6425fd8ac055819ce8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749578873,
      "headline": "Vertex Pharmaceuticals Incorporated (VRTX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript",
      "id": 135170581,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Goldman Sachs 46th Annual Global Healthcare Conference Call June 10, 2025 2:40 PM ETCompany...",
      "url": "https://finnhub.io/api/news?id=ef4d70f5a7a8d4ad5562c2271493d452c19b86c8e4211e6425fd8ac055819ce8"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Vertex Pharmaceuticals Incorporated Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 02",
    "summary": "Presenter SpeechSalveen Richter Good afternoon, everyone. Thank you so much for joining us. I'm Salveen Richter, biotechnology at Goldman Sachs and really pleased to be joined by the Vertex team.",
    "url": "https://finnhub.io/api/news?id=d8d1a4bb0a8cfe77c19ebbfdd11832255d4203f177bb0d7ba2e2842b50722523",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749576238,
      "headline": "Transcript : Vertex Pharmaceuticals Incorporated Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 02",
      "id": 135170757,
      "image": "",
      "related": "VRTX",
      "source": "Finnhub",
      "summary": "Presenter SpeechSalveen Richter Good afternoon, everyone. Thank you so much for joining us. I'm Salveen Richter, biotechnology at Goldman Sachs and really pleased to be joined by the Vertex team.",
      "url": "https://finnhub.io/api/news?id=d8d1a4bb0a8cfe77c19ebbfdd11832255d4203f177bb0d7ba2e2842b50722523"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=c7cae2520762801a1263d6702b00d4b0bf56aee7f695635403c20b4e0a16f85f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749573420,
      "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 135184588,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=c7cae2520762801a1263d6702b00d4b0bf56aee7f695635403c20b4e0a16f85f"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Exec Says Cystic Fibrosis Portfolio Has About 9% Exposure To Medicare And About 23% Exposure To Medicaid - Goldman Sachs Conference",
    "summary": "Vertex Pharmaceuticals Inc: * VERTEX PHARMACEUTICALS EXEC SAYS CYSTIC FIBROSIS PORTFOLIOHASABOUT 9% EXPOSURE TO MEDICARE AND ABOUT 23% EXPOSURE TO MEDICAID- GOLDMAN SACHS CONFERENCE ...",
    "url": "https://finnhub.io/api/news?id=aabdb5a426fd56f52c60e1037b1e1f801395fc4526f48afe6c306180c68e3883",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749568694,
      "headline": "Vertex Pharmaceuticals Exec Says Cystic Fibrosis Portfolio Has About 9% Exposure To Medicare And About 23% Exposure To Medicaid - Goldman Sachs Conference",
      "id": 135169520,
      "image": "",
      "related": "VRTX",
      "source": "Finnhub",
      "summary": "Vertex Pharmaceuticals Inc: * VERTEX PHARMACEUTICALS EXEC SAYS CYSTIC FIBROSIS PORTFOLIOHASABOUT 9% EXPOSURE TO MEDICARE AND ABOUT 23% EXPOSURE TO MEDICAID- GOLDMAN SACHS CONFERENCE ...",
      "url": "https://finnhub.io/api/news?id=aabdb5a426fd56f52c60e1037b1e1f801395fc4526f48afe6c306180c68e3883"
    }
  },
  {
    "ts": null,
    "headline": "1 Nasdaq 100 Stock for Long-Term Investors and 2 to Ignore",
    "summary": "The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like profitability concerns, rising costs, or shifts in market trends.",
    "url": "https://finnhub.io/api/news?id=2a4d3afdc83104153ffb09aa56484b71582432197f071269ceb7187ceaccbae0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749530045,
      "headline": "1 Nasdaq 100 Stock for Long-Term Investors and 2 to Ignore",
      "id": 135147755,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like profitability concerns, rising costs, or shifts in market trends.",
      "url": "https://finnhub.io/api/news?id=2a4d3afdc83104153ffb09aa56484b71582432197f071269ceb7187ceaccbae0"
    }
  }
]